biopharmaceutical company that manufactures an immunotherapy for prostate cancer
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2021 | DENDREON PHARMACEUTICALS, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $120,000 | |
| 2020 | DENDREON PHARMACEUTICALS, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $120,000 | |
| 2020 | DENDREON PHARMACEUTICALS, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $120,000 | |
| 2020 | DENDREON PHARMACEUTICALS, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $120,000 | |
| 2020 | DENDREON PHARMACEUTICALS, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $120,000 | |
| 2019 | DENDREON PHARMACEUTICALS, LLC |
3rd Quarter (July 1 - Sep 30) AMENDED |
— | $58,750 | |
| 2019 | DENDREON PHARMACEUTICALS, LLC |
2nd Quarter (Apr 1 - June 30) AMENDED |
— | $48,750 | |
| 2019 | DENDREON PHARMACEUTICALS, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $118,750 | |
| 2019 | DENDREON PHARMACEUTICALS, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $58,750 | |
| 2019 | DENDREON PHARMACEUTICALS, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $48,750 |
| Client | Filings | Total Income |
|---|---|---|
| DENDREON PHARMACEUTICALS, LLC | 32 | — |
| Name | Disclosed Prior Position |
|---|---|
| ANDREW SAELENS |